Finance
Ashok Chennuru, global chief data and insights officer at Elevance Health, and Oron Afek, CEO of Vim, discuss scaling artificial intelligence to accelerate workflows, enhance patient care and unlock personalized medicine.
Healthcare attorney and partner at Holland & Knight Zubin Khambatta discusses the CMS final rule related to Medicaid managed care and its provisions adding new compliance guardrails regarding state-directed payments.
HIMSS24
Jorie AI CEO Sal Lo discusses his company's product that helps reduce administrative workload and enables healthcare organizations to speed up eligibility verification and claims processing.
Cyberwrite President Hartmut Mai discusses the Change Healthcare ransomware attack and how chain reaction cyberattacks could affect cyber insurance opportunities.
Dr. Yusuf Sherwani, CEO and cofounder of Pelago, describes how the company partners with employers and health plans to control the costs of substance misuse disorders and the effectiveness of the virtual evidence-based treatment platform.
Rich Miller, chief innovation officer at QGenda, says that health systems need to address burnout, staffing and employee issues in a less fragmented way.
Aytan Dahukey, partner and private equity team leader, and healthcare team member at Sheppard Mullin, says that growth areas in private equity are opportunistic and discusses some challenges ahead.
HIMSS24
Dr. Harm Scherpbier, HealthShare Exchange CMIO, describes how the company's platform connects practices, payers and ACOs, allowing them to share patients’ data in real time across facilities to coordinate care seamlessly.
Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.